{"transactions":[{"id":4507438,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":180068,"kind":"person","name":"Rooke Andrew K.","position":1,"cik":"0001540174","reported_name":"Rooke Andrew K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-03T22:00:31.000Z","date":"2016-12-30","kind":"grant","acquired":true,"shares":1801,"price":2.64,"value":4754.64,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under such plan. The shares were issued at a price of $2.64 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended December 30, 2016."}],"balance_after":27982,"source":{"system":"sec-edgar","filing":"0001534424-17-000016","document":"rooke.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000153442417000016/rooke.xml","form_type":"4"}},{"id":4586477,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":180068,"kind":"person","name":"Rooke Andrew K.","position":1,"cik":"0001540174","reported_name":"Rooke Andrew K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-10-04T20:34:04.000Z","date":"2016-09-30","kind":"grant","acquired":true,"shares":638,"price":6.65,"value":4242.7,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under such plan. The shares were issued at a price of $6.65 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended September 30, 2016."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This amount corrects a typographical error, which inadvertently overstated the reporting person's holdings, in the previously filed Form 4."}],"balance_after":26181,"source":{"system":"sec-edgar","filing":"0001534424-16-001071","document":"rooke.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000153442416001071/rooke.xml","form_type":"4"}},{"id":4609275,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":180068,"kind":"person","name":"Rooke Andrew K.","position":1,"cik":"0001540174","reported_name":"Rooke Andrew K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants(5) (right to buy)","published_at":"2016-09-07T22:39:20.000Z","date":"2014-03-25","kind":"purchase","acquired":true,"shares":7500,"ownership":{"direct":false,"nature":"By trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"These warrants were previously reported on the Form 4 filed with the Securities and Exchange Commission on March 26, 2014. This line item reflects the current exercise price of such warrants resulting from anti-dilution adjustments made pursuant to the Second Omnibus Amendment triggered by the Private Placement, on a post reverse stock split basis,."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported securities are included within 200,000 units sold to the Reporting Person for $5.00 per unit upon the automatic conversion of the $1,000,000 principal balance of the 12% Second-Priority Secured Non-Convertible Promissory Note Due 2019 dated as of March 25, 2014 (\"2019 Note\") issued to and held by the Reporting Person, as amended by that certain Omnibus Amendment dated as of June 30, 2016 and that certain Second Omnibus Amendment dated as of August 31, 2016 (the \"Second Omnibus Amendment\"). Each unit consists of one share of common stock and one warrant to purchase 0.90 share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to this warrant are immediately exercisable."}],"balance_after":7500,"derivative":{"exercise_price":5.5,"exercise_date":"2014-03-25","expiration_date":"2019-03-25","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001534424-16-001013","document":"rooke.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000153442416001013/rooke.xml","form_type":"4"}},{"id":4609274,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":180068,"kind":"person","name":"Rooke Andrew K.","position":1,"cik":"0001540174","reported_name":"Rooke Andrew K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants (right to buy)","published_at":"2016-09-07T22:39:20.000Z","date":"2016-09-02","kind":"exercise","acquired":true,"shares":180000,"ownership":{"direct":false,"nature":"By trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported securities are included within 200,000 units sold to the Reporting Person for $5.00 per unit upon the automatic conversion of the $1,000,000 principal balance of the 12% Second-Priority Secured Non-Convertible Promissory Note Due 2019 dated as of March 25, 2014 (\"2019 Note\") issued to and held by the Reporting Person, as amended by that certain Omnibus Amendment dated as of June 30, 2016 and that certain Second Omnibus Amendment dated as of August 31, 2016 (the \"Second Omnibus Amendment\"). Each unit consists of one share of common stock and one warrant to purchase 0.90 share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to this warrant are immediately exercisable."}],"balance_after":180000,"derivative":{"exercise_price":5.5,"exercise_date":"2016-09-02","expiration_date":"2021-09-02","underlying":"Common Stock","underlying_shares":180000},"source":{"system":"sec-edgar","filing":"0001534424-16-001013","document":"rooke.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000153442416001013/rooke.xml","form_type":"4"}},{"id":4609273,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":180068,"kind":"person","name":"Rooke Andrew K.","position":1,"cik":"0001540174","reported_name":"Rooke Andrew K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"2009 Note","published_at":"2016-09-07T22:39:20.000Z","date":"2016-09-02","kind":"exercise","acquired":false,"price":5,"reported_value":1000000,"ownership":{"direct":false,"nature":"By trust"},"footnotes":[{"field":"reported_value","element":"transactionTotalValue","label":"F3","text":"Upon the closing of the Issuer's private placement on September 2, 2016 (the \"Private Placement\"), in accordance with the terms and conditions of the Second Omnibus Amendment, the $1,000,000 principal balance of the 2019 Note held by the Reporting Person automatically converted into 200,000 units issued and sold to the Reporting Person based on the $5.00 offering price in the Private Placement. Each unit consists of common stock and one warrant to purchase 0.90 share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Upon the closing of the Issuer's private placement on September 2, 2016 (the \"Private Placement\"), in accordance with the terms and conditions of the Second Omnibus Amendment, the $1,000,000 principal balance of the 2019 Note held by the Reporting Person automatically converted into 200,000 units issued and sold to the Reporting Person based on the $5.00 offering price in the Private Placement. Each unit consists of common stock and one warrant to purchase 0.90 share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Upon the closing of the Issuer's private placement on September 2, 2016 (the \"Private Placement\"), in accordance with the terms and conditions of the Second Omnibus Amendment, the $1,000,000 principal balance of the 2019 Note held by the Reporting Person automatically converted into 200,000 units issued and sold to the Reporting Person based on the $5.00 offering price in the Private Placement. Each unit consists of common stock and one warrant to purchase 0.90 share of common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Upon the closing of the Issuer's private placement on September 2, 2016 (the \"Private Placement\"), in accordance with the terms and conditions of the Second Omnibus Amendment, the $1,000,000 principal balance of the 2019 Note held by the Reporting Person automatically converted into 200,000 units issued and sold to the Reporting Person based on the $5.00 offering price in the Private Placement. Each unit consists of common stock and one warrant to purchase 0.90 share of common stock."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"Upon the closing of the Issuer's private placement on September 2, 2016 (the \"Private Placement\"), in accordance with the terms and conditions of the Second Omnibus Amendment, the $1,000,000 principal balance of the 2019 Note held by the Reporting Person automatically converted into 200,000 units issued and sold to the Reporting Person based on the $5.00 offering price in the Private Placement. Each unit consists of common stock and one warrant to purchase 0.90 share of common stock."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"Upon the closing of the Issuer's private placement on September 2, 2016 (the \"Private Placement\"), in accordance with the terms and conditions of the Second Omnibus Amendment, the $1,000,000 principal balance of the 2019 Note held by the Reporting Person automatically converted into 200,000 units issued and sold to the Reporting Person based on the $5.00 offering price in the Private Placement. Each unit consists of common stock and one warrant to purchase 0.90 share of common stock."}],"balance_after":0,"derivative":{"exercise_price":5,"underlying":"Unit"},"source":{"system":"sec-edgar","filing":"0001534424-16-001013","document":"rooke.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000153442416001013/rooke.xml","form_type":"4"}},{"id":4609272,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":180068,"kind":"person","name":"Rooke Andrew K.","position":1,"cik":"0001540174","reported_name":"Rooke Andrew K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants (right to buy)","published_at":"2016-09-07T22:39:20.000Z","date":"2016-09-02","kind":"purchase","acquired":true,"shares":9000,"ownership":{"direct":false,"nature":"By trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 40,000 units purchased by the Reporting Person for $5.00 per unit. Each unit consists of one share of common stock and one warrant to purchase 0.90 share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to this warrant are immediately exercisable."}],"balance_after":9000,"derivative":{"exercise_price":5.5,"exercise_date":"2016-09-02","expiration_date":"2021-09-02","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001534424-16-001013","document":"rooke.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000153442416001013/rooke.xml","form_type":"4"}},{"id":4609271,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":180068,"kind":"person","name":"Rooke Andrew K.","position":1,"cik":"0001540174","reported_name":"Rooke Andrew K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-09-07T22:39:20.000Z","date":"2016-09-02","kind":"exercise","acquired":true,"shares":200000,"ownership":{"direct":false,"nature":"By trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported securities are included within 200,000 units sold to the Reporting Person for $5.00 per unit upon the automatic conversion of the $1,000,000 principal balance of the 12% Second-Priority Secured Non-Convertible Promissory Note Due 2019 dated as of March 25, 2014 (\"2019 Note\") issued to and held by the Reporting Person, as amended by that certain Omnibus Amendment dated as of June 30, 2016 and that certain Second Omnibus Amendment dated as of August 31, 2016 (the \"Second Omnibus Amendment\"). Each unit consists of one share of common stock and one warrant to purchase 0.90 share of common stock."}],"balance_after":210000,"source":{"system":"sec-edgar","filing":"0001534424-16-001013","document":"rooke.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000153442416001013/rooke.xml","form_type":"4"}},{"id":4609270,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":180068,"kind":"person","name":"Rooke Andrew K.","position":1,"cik":"0001540174","reported_name":"Rooke Andrew K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-09-07T22:39:20.000Z","date":"2016-09-02","kind":"purchase","acquired":true,"shares":10000,"ownership":{"direct":false,"nature":"By trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 40,000 units purchased by the Reporting Person for $5.00 per unit. Each unit consists of one share of common stock and one warrant to purchase 0.90 share of common stock."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001534424-16-001013","document":"rooke.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000153442416001013/rooke.xml","form_type":"4"}}]}